Currently in clinic, people use hematoxylin and eosin stain (H&E stain) and immunohistochemistry methods to identify the generation and genre of cancers for human pathological samples. Since these methods are inaccurate and time consuming, developing a rapid and accurate method to detect cancer is urgently demanded. In our study, binding peptides for lung cancer cell line A549 were identified using bacteria surface display method. With those binding peptides for A549 cells on the surface, the fluorescent bacteria (Escherichia coli with stably expressed green fluorescent protein) were served as specific detecting reagents for the diagnosis of cancers. The binding activity of peptide-fluorescent bacteria complex was confirmed by detached cancer cells, attached cancer cells and mice tumor xenograft samples. A unique fixation method was developed for peptide-bacteria complex in order to make this complex more feasible for the clinic use. This peptide-fluorescent bacteria complex has great potential to become a new diagnostic tool for clinical application.
References
[1]
Gao XH, Cui YY, Levenson RM, Chung LWK, Nie SM (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nature Biotechnology 22: 969–976.
[2]
Wang F, Banerjee D, Liu YS, Chen XY, Liu XG (2010) Upconversion nanoparticles in biological labeling, imaging, and therapy. Analyst 135: 1839–1854.
[3]
Xu RX, Povoski SP, Martin EW (2010) Targeted delivery of microbubbles and nanobubbles for image-guided thermal ablation therapy of tumors. Expert Review of Medical Devices 7: 303–306.
[4]
Scott AM, Wolchok JD, Old LJ (2012) Antibody therapy of cancer. Nature Reviews Cancer 12: 278–287.
[5]
Graham MM, Menda Y (2011) Radiopeptide Imaging and Therapy in the United States. Journal of Nuclear Medicine 52: 56s–63s.
[6]
Bidwell GL (2012) Peptides for cancer therapy: a drug-development opportunity and a drug-delivery challenge. Ther Deliv 3: 609–621.
[7]
Shi H, He XX, Wang KM, Wu X, Ye XS, et al. (2011) Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alteration. Proceedings of the National Academy of Sciences of the United States of America 108: 3900–3905.
[8]
Ardeshirpour Y, Chernomordik V, Zielinski R, Capala J, Griffiths G, et al. (2012) In Vivo Fluorescence Lifetime Imaging Monitors Binding of Specific Probes to Cancer Biomarkers. Plos One 7.
[9]
Stahl S, Uhlen M (1997) Bacterial surface display: Trends and progress. Trends in Biotechnology 15: 185–192.
[10]
Francisco JA, Campbell R, Iverson BL, Georgiou G (1993) Production and Fluorescence-Activated Cell Sorting of Escherichia-Coli Expressing a Functional Antibody Fragment on the External Surface. Proceedings of the National Academy of Sciences of the United States of America 90: 10444–10448.
[11]
Wernerus H, Stahl S (2004) Biotechnological applications for surface-engineered bacteria. Biotechnology and Applied Biochemistry 40: 209–228.
[12]
Bessette PH, Rice JJ, Daugherty PS (2004) Rapid isolation of high-affinity protein binding peptides using bacterial display. Protein Engineering Design & Selection 17: 731–739.
[13]
Dane KY, Chan LA, Rice JJ, Daugherty PS (2006) Isolation of cell specific peptide ligands using fluorescent bacterial display libraries. Journal of Immunological Methods 309: 120–129.
[14]
Boulware KT, Daugherty PS (2006) Protease specificity determination by using cellular libraries of peptide substrates (CLiPS). Proceedings of the National Academy of Sciences of the United States of America 103: 7583–7588.
[15]
Feng SP, Cong SJ, Zhang X, Bao XC, Wang W, et al. (2011) MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Research 39: 6669–6678.
[16]
Qu DZ, Wang GX, Wang Z, Zhou L, Chi WL, et al. (2011) 5-Ethynyl-2′-deoxycytidine as a new agent for DNA labeling: Detection of proliferating cells. Analytical Biochemistry 417: 112–121.
[17]
Gao YZ, He Y, Ding J, Wu K, Hu B, et al. (2009) An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1 alpha 3′ untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis 30: 2064–2069.
[18]
Liu GJ, Ma SB, Li SK, Cheng R, Meng FH, et al. (2010) The highly efficient delivery of exogenous proteins into cells mediated by biodegradable chimaeric polymersomes. Biomaterials 31: 7575–7585.
[19]
Guzman LM, Belin D, Carson MJ, Beckwith J (1995) Tight Regulation, Modulation, and High-Level Expression by Vectors Containing the Arabinose P-Bad Promoter. Journal of Bacteriology 177: 4121–4130.
[20]
van Essen HF, Verdaasdonk MAM, Elshof SM, de Weger RA, van Diest PJ (2010) Alcohol based tissue fixation as an alternative for formaldehyde: influence on immunohistochemistry. Journal of Clinical Pathology 63: 1090–1094.
[21]
Brown MV, McDunn JE, Gunst PR, Smith EM, Milburn MV, et al. (2012) Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsies. Genome Med 4: 33.
[22]
Bonaccorsi S, Giansanti MG, Cenci G, Gatti M (2011) Methanol-acetone fixation of Drosophila testes. Cold Spring Harb Protoc 2011: 1270–1272.
[23]
Yildiz-Aktas IZ, Dabbs DJ, Cooper KL, Chivukula M, McManus K, et al. (2012) The Effect of 96-Hour Formalin Fixation on the Immunohistochemical Evaluation of Estrogen Receptor, Progesterone Receptor, and HER2 Expression in Invasive Breast Carcinoma. American Journal of Clinical Pathology 137: 691–698.
[24]
Esposito CL, Passaro D, Longobardo I, Condorelli G, Marotta P, et al. (2011) A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death. Plos One 6.
[25]
Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, et al. (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death and Differentiation 15: 504–514.
[26]
Yaghoubi SS, Jensen MC, Satyamurthy N, Budhiraja S, Paik D, et al. (2009) Noninvasive detection of therapeutic cytolytic T cells with F-18-FHBG PET in a patient with glioma. Nature Clinical Practice Oncology 6: 53–58.
[27]
Suzuki Y, Cunningham CH, Noguchi KI, Chen IY, Weissman IL, et al. (2008) In Vivo Serial Evaluation of Superparamagnetic Iron-Oxide Labeled Stem Cells by Off-Resonance Positive Contrast. Magnetic Resonance in Medicine 60: 1269–1275.
[28]
Mace E, Montaldo G, Cohen I, Baulac M, Fink M, et al. (2011) Functional ultrasound imaging of the brain. Nature Methods 8: 662–664.
[29]
Pichler BJ, Kolb A, Nagele T, Schlemmer HP (2010) PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications. Journal of Nuclear Medicine 51: 333–336.
[30]
Cronin M, Akin AR, Collins SA, Meganck J, Kim JB, et al. (2012) High Resolution In Vivo Bioluminescent Imaging for the Study of Bacterial Tumour Targeting. Plos One 7.
[31]
Puchtler H, Meloan SN, Waldrop FS (1986) Application of Current Chemical Concepts to Metal-Hematein and Metal-Brazilein Stains. Histochemistry 85: 353–364.
[32]
Ramos-Vara JA (2005) Technical aspects of immunohistochemistry. Veterinary Pathology 42: 405–426.
[33]
Heatley MK (2012) A Systematic Review of Papers Examining the Use of Intraoperative Frozen Section in Predicting the Final Diagnosis of Ovarian Lesions. International Journal of Gynecological Pathology 31: 111–115.
[34]
Singh B, Chaturvedi P, Nair S, D’cruz A, Kane SV (2011) Utility of frozen section in assessment of margins and neck node metastases in patients undergoing surgery for the carcinoma of the tongue. Oral Oncology 47: S70–S70.
